{"text": ["Health", "Care", "Sector", "Update", "for", "11/13/2018:", "ABBV,VKTX,CRON,CRON.TO,VLRX"], "created_at": "2018-11-13 21:26:52"}
{"text": ["Health", "Care", "Sector", "Update", "for", "11/13/2018:", "ABBV,VKTX,CRON,CRON.TO,VLRX"], "created_at": "2018-11-13 21:26:52"}
{"text": ["AbbVie's", "MAVYRET\u2122", "(glecaprevir/pibrentasvir)", "Shows", "High", "Virologic", "Cure*", "Rates", "in", "Treatment-Na\u00efve", "Hepatitis", "C", "Patients", "with", "Compensated", "Cirrhosis"], "created_at": "2018-11-13 16:30:00"}
{"text": ["Better", "Buy:", "AbbVie", "Inc.", "vs.", "GlaxoSmithKline", "PLC"], "created_at": "2018-11-13 14:09:52"}
{"text": ["Better", "Buy:", "AbbVie", "Inc.", "vs.", "GlaxoSmithKline", "PLC"], "created_at": "2018-11-13 14:09:52"}
{"text": ["AbbVie", "to", "Present", "at", "the", "Evercore", "ISI", "Conference"], "created_at": "2018-11-13 13:00:00"}
{"text": ["Better", "Buy:", "AbbVie", "Inc.", "vs.", "GlaxoSmithKline", "PLC"], "created_at": "2018-11-13 11:31:00"}
